FDA Hesitates On COVID Blood Plasma Treatment; Trump Isn’t Pleased : Coronavirus Live Updates – NPR
Convalescent serum or blood plasma from a recovered COVID-19 patients is being studied as a treatment for others with the disease. The FDA is holding off on giving it emergency use authorization.
President Trump suggested in recent comments that there is a treatment for COVID-19 that members of his own administration are slow-walking to thwart his reelection bid.
The treatment is something called convalescent plasma. Since April, the Food and Drug Administration has been enc…